Cargando…

Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma

BACKGROUND: Dihydropyrimidinase-like 3 (DPYSL3) is a cytosolic phosphoprotein expressed in the nervous system and is crucial for neurogenesis. A previous study showed that increased DPYSL3 expression promotes tumour aggressiveness in pancreatic ductal adenocarcinoma, gastric cancer, and colon cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Peir-In, Lai, Hong-Yue, Chan, Ti-Chun, Li, Wei-Ming, Hsing, Chung-Hsi, Huang, Steven K., Hsieh, Kun-Lin, Tseng, Wen-Hsin, Chen, Tzu-Ju, Li, Wan-Shan, Chen, Huan-Da, Kuo, Yu-Hsuan, Li, Chien-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304234/ https://www.ncbi.nlm.nih.gov/pubmed/37380971 http://dx.doi.org/10.1186/s12885-023-11090-z

Ejemplares similares

Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma
por: Kuo, Yu-Hsuan, et al.
Publicado: (2022)

Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma
por: Kuo, Yu-Hsuan, et al.
Publicado: (2021)

Upregulation of Thr/Tyr kinase Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer
por: Tsai, Ying-Ming, et al.
Publicado: (2020)

Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder
por: Lee, Yi-Ying, et al.
Publicado: (2016)

Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2014)

Inhibition of cell-adhesion protein DPYSL3 promotes metastasis of lung cancer
por: Yang, Yang, et al.
Publicado: (2018)

Angiogenesis Driven by the CEBPD–hsa-miR-429–VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression
por: Chan, Ti-Chun, et al.
Publicado: (2022)

Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder
por: He, Hong-Lin, et al.
Publicado: (2023)

The DPYSL2 gene connects mTOR and schizophrenia
por: Pham, X, et al.
Publicado: (2016)

High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis
por: Lai, Hong-Yue, et al.
Publicado: (2022)

Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract
por: Lee, Hsiang-Ying, et al.
Publicado: (2017)

Serum Dihydropyrimidinase-Like 3 Concentration in Patients with Gastric Cancer and Its Diagnostic Value
por: Zhong, Huiqiu, et al.
Publicado: (2021)

HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma
por: Liang, Peir-In, et al.
Publicado: (2012)

High Expression of 17β-hydroxysteroid Dehydrogenase Type 2 is Associated with a Better Prognosis in Urothelial Carcinoma of the Urinary Tract
por: Wang, Chieh-Tien, et al.
Publicado: (2016)

Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation
por: Umetsu, Satoko, et al.
Publicado: (2020)

Dihydropyrimidinase from Saccharomyces kluyveri can hydrolyse polyamides
por: Quartinello, Felice, et al.
Publicado: (2023)

DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer
por: Matsunuma, Ryoichi, et al.
Publicado: (2018)

SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma
por: Ma, Li-Jung, et al.
Publicado: (2016)

Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis
por: Li, Changlin, et al.
Publicado: (2016)

Complement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

Signature literature review reveals AHCY, DPYSL3, and NME1 as the most recurrent prognostic genes for neuroblastoma
por: Chicco, Davide, et al.
Publicado: (2023)

DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma
por: Wu, Yang-Jie, et al.
Publicado: (2021)

Structural Basis for pH-Dependent Oligomerization of Dihydropyrimidinase from Pseudomonas aeruginosa PAO1
por: Cheng, Jen-Hao, et al.
Publicado: (2018)

Genetic Polymorphisms of Dihydropyrimidinase in a Japanese Patient with Capecitabine-Induced Toxicity
por: Hiratsuka, Masahiro, et al.
Publicado: (2015)

Rational Engineering of the Substrate Specificity of a Thermostable D-Hydantoinase (Dihydropyrimidinase)
por: Aganyants, Hovsep, et al.
Publicado: (2020)

Dihydropyrimidinase protects from DNA replication stress caused by cytotoxic metabolites
por: Basbous, Jihane, et al.
Publicado: (2020)

Contribution of the dihydropyrimidinase-like proteins family in synaptic physiology and in neurodevelopmental disorders
por: Desprez, Florence, et al.
Publicado: (2023)

CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma
por: Lee, Yi-Ying, et al.
Publicado: (2016)

MON-316 DPYSL4 Regulates Oxygen Consumption Associating with Mitochondrial Supercomplexes
por: Tanaka, Tomoaki, et al.
Publicado: (2019)

DPYSL2 interacts with JAK1 to mediate breast cancer cell migration
por: Abu Rmaileh, Areej, et al.
Publicado: (2022)

Patients with urothelial carcinoma have poor renal outcome regardless of whether they receive nephrouretectomy
por: Hung, Peir-Haur, et al.
Publicado: (2016)

CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas
por: Hsu, Wei-Chi, et al.
Publicado: (2019)

In Vitro Assessment of Fluoropyrimidine-Metabolizing Enzymes: Dihydropyrimidine Dehydrogenase, Dihydropyrimidinase, and β-Ureidopropionase
por: Hishinuma, Eiji, et al.
Publicado: (2020)

MCM10 overexpression implicates adverse prognosis in urothelial carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2016)

Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia
por: Li, Fenglin, et al.
Publicado: (2023)

Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2020)

DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study
por: Tsai, Meng-Chen, et al.
Publicado: (2016)

Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

DPYSL2 is a novel regulator for neural stem cell differentiation in rats: revealed by Panax notoginseng saponin administration
por: Xiong, Liu-Lin, et al.
Publicado: (2020)

Expression of Concern: Genetic Polymorphisms of Dihydropyrimidinase in a Japanese Patient with Capecitabine-Induced Toxicity
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6ovr0ftn5ouohp1oq1h4q6ag93